A Single Blinded, Cross-Sectional, Single-Center Study for the Validation of Atrial Fibrillation Detection using Spandan Smartphone ECG

A Single Blinded, Cross-Sectional, Single-Center Study for the Validation of Atrial Fibrillation Detection using Spandan Smartphone ECG

Download Citation in txt Download Citation in bib Download Citation in ris

Author Info

Corresponding Author
Nitin Chandola
Department of Research and Technology, Sunfox Technologies Pvt. Ltd, Dehradun, India

A B S T R A C T

The atrial fibrillation prevalence is found between 0.1% and 4% in community-based research and between 2.8% and 14% in studies conducted in hospitals; nevertheless, a large portion of AF is still misdiagnosed. Smartphone applications for diagnosing AF have been proposed given that a big portion of Indians own smartphones, although it is unknown how accurate these programs would be. The study's objectives were as follows: a) To evaluate the diagnostic efficacy of the Spandan ECG in detecting AF in a single center trial that took place in SMIH Dehradun under the supervision of the cardiologist, and b) to investigate arrhythmia detection through a smartphone-based and monitoring. This single-blinded, cross-sectional, single-center study was conducted at Shri Mahant Indresh Hospital (SMIH), Dehradun, Uttarakhand, India from August 2022 to December 2022. Patients (n=32) undergoing the electrocardiogram (ECG) at the Department of Cardiology of the SMIH, Dehradun during the study period and diagnosed with atrial fibrillation. Mean age (SD) was 59.93±13.81 years. Males (n=17/32, 53.1%) show more frequency than females. Most patients had a medical history of coronary artery disease (21.8%). True positive cases derived from confusion matrix of atrial fibrillation detected using smartphone based ECG and 12 lead standard ECG along with the cardiologist’s diagnosis was 29/32 on smartphone-based as compared to 19/32 from 12 lead gold standard. Atrial fibrillation was detected correctly in 29/32 cases and 19/32 cases by smartphone ECG and 12 lead gold standard, respectively. The study hypotheses that Spandan's ability of real-time ECG monitoring will be useful in evaluating whether a patient's discomfort is caused by recurrent arrhythmia.

Article Info

Article Type
Research Article
Publication history
Received: Tue 04, Jul 2023
Accepted: Thu 20, Jul 2023
Published: Tue 08, Aug 2023
Copyright
© 2023 Nitin Chandola. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.JICOA.2023.01.04